CNP-201 in Subjects With Peanut Allergy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This study is a Phase 1b/2a clinical trial to assess the safety, tolerability, and pharmacodynamics of multiple ascending doses (Escalation Phase) of CNP-201 with the goal of identifying a safe and tolerable dose level to be evaluated further in a larger number of subjects (Expansion Phase).
Epistemonikos ID: d7757034904f0519fc60d8ac5088ffacb207a12a
First added on: Oct 02, 2023